文献速递多重用药衰弱、肌少症与跌倒老年慢病共病管理

多重用药与HIV感染者及非感染者住院风险关联的观察性研究

Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study.
PubMed 文献 · Lancet Healthy Longev · 2021-09-29

BACKGROUND: Polypharmacy, defined as use of five or more medications concurrently, is associated with adverse health outcomes and people ageing with HIV might be at greater risk than similar uninfected individuals.…

要点

  • HIV感染者每增加一种药物,比非感染者产生更多药物相互作用。
  • 校正衰弱和KPDI后,每增加一种非ART药物仍与住院风险升高相关。
  • 真实用药组合的KPDI数量远高于随机抽样组合。

核心结论

  • 对于每增加一种药物,年长HIV感染者比非感染者有更多的药物相互作用。
  • 校正已知非ART药物相互作用后,每增加一种非ART药物,HIV感染者住院风险仍增加。

研究设计与样本

  • 使用随机选择与实际用药模式比较2至12种药物时的KPDI计数,并构建加权KPDI指数,采用按HIV状态分层的嵌套Cox模型估计药物数量与住院风险的关联。

临床怎么用

  • 在管理年长HIV感染者多重用药时,应关注非ART药物之间的已知相互作用,即使校正衰弱后仍需警惕每增加一种非ART药物带来的住院风险升高。
  • 真实用药组合的KPDI数量远高于随机组合,提示临床应基于实际用药方案评估相互作用而非仅关注药物数量。

局限性

  • 原文未报告随机对照试验证据,作者指出需要随机试验来确定减少这些相互作用是否能改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polypharmacy, defined as use of five or more medications concurrently, is associated with adverse health outcomes and people ageing with HIV might be at greater risk than similar uninfected individuals. We aimed to determine whether known pairwise drug interactions (KPDIs) were associated with risk of admission to hospital (hereafter referred to as hospitalisation) and medication count among people ageing with and without HIV after accounting for physiological frailty. METHODS: In this observational study, we collected individual-level data for participants of the Veterans Aging Cohort Study (VACS) with HIV on antiretroviral therapy (ART) and with supressed HIV-1 RNA and people without HIV who were receiving at least one prescription medication, based on active medications in the 2009 fiscal year (ie, Oct 1, 2008, to Sept 30, 2009). We identified KPDIs among these patients by linking prescription fill and refill data with data from DrugBank (version 5.0.11). We collected data on all-cause mortality and hospitalisations between Oct 1, 2009, and March 31, 2019. We compared KPDI counts using random selection and actual patterns of use across medication counts from two to 12. We created a weighted KPDI Index on the basis of the average association of each KPDI with mortality among people ageing without HIV and used nested Cox models stratified by HIV status to estimate the association between medication count and hospitalisation, with incremental adjustments for demographics, physiological frailty, and KPDI Index. FINDINGS: We collected data for 9186 people ageing with HIV and 37 930 individuals without HIV. 45 913 (97·4%) of 47 116 patients were men and the sample was predominantly aged 50-64 years (30 413 [64·6%]). Compared with a random sample of medications, real-world pattern of medication counts and combinations were associated with five-to-six times more KPDIs (eg, for a combination of six medications, KPDI count was 1·09 in the random sample, 5·49 in the HIV-negative population, and 7·13 in the HIV-positive population). For each additional observed medication, people ageing with HIV had approximately 2·94 additional KPDIs and comparators had approximately 2·67 additional KPDIs. Adjustment for demographics, physiological frailty, and KPDI Index reduced the association between medication count and risk of hospitalisation for people ageing with HIV (hazard ratio 1·08 [95% CI 1·07-1·09] reduced to 1·06 [1·05-1·07]) and those without HIV (1·08 [1·07-1·08] reduced to 1·04 [1·03-1·05]). INTERPRETATION: For each additional medication, people ageing with HIV have more drug-drug interactions than those without HIV. Adjusting for known non-ART drug-drug interactions, each additional non-ART medication confers excess risk of hospitalisation for people ageing with HIV. Randomised trials will be needed to determine whether reducing these interactions improves outcomes. FUNDING: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Department of Veterans Affairs Health Services Research & Development, and Office of Research and Development.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Justice AC, Gordon KS, Romero J, et al. Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study. Lancet Healthy Longev. 2021. PMID: 34870254. doi:10.1016/S2666-7568(21)00206-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。